Discontinuation report NORVIR

Last updated on 2019-04-01 History
Report ID 76354
Drug Identification Number 02229145
Brand name NORVIR
Common or Proper name Norvir Oral Solution
Company Name ABBVIE CORPORATION
Active Ingredient(s) RITONAVIR
Strength(s) 80MG
Dosage form(s) SOLUTION
Route of administration ORAL
Packaging size 240mL
ATC code J05AE
ATC description DIRECT ACTING ANTIVIRALS
Reason for discontinuation Business reasons
Anticipated discontinuation date 2019-03-31
Actual discontinuation date 2019-03-31
Remaining supply date 2019-03-31
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply Norvir Oral Solution sales by AbbVie Corporation will cease on March 31, 2019. Last lot available on the market expires in May 2019.
Company comments AbbVie routinely and carefully assesses our portfolio, including our existing and anticipated pipeline to determine what is best for our customers and our business. This decision is in line with Norvir’s phase in the product lifecycle.
Health Canada comments
Contact Address 8401 TRANS-CANADA HIGHWAY
SAINT-LAURENT, QUEBEC
CANADA H4S 1Z1
Company contact information Should you require any additional information, please contact our Customer Service Department at 1-888-704-8270.

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2019-04-01 English Compare
v4 2019-02-20 French Compare
v3 2019-02-20 English Compare
v2 2019-02-20 French Compare
v1 2019-02-20 English Compare